Brain Health
Psilocybin Therapy Shows Promise for End-of-Life Psychological Distress
Pilot study tests psilocybin-assisted psychotherapy to help hospice patients overcome demoralization and existential suffering.
Clinical Trial
Mar 28, 2026 1
Alzheimer's
478 articles in this topic
Brain Health
Yale Psilocybin Trial for Post-Concussion Headaches Shows Promise Despite Early End
Small Yale study tested magic mushroom compound for chronic headaches after brain injury, tracking symptoms and inflammation markers.
Clinical Trial
Mar 28, 2026 1
Brain Health
Psilocybin Shows Promise for Obsessive-Compulsive Disorder in Yale Clinical Trial
Yale researchers tested psilocybin's effects on OCD symptoms in a controlled trial, exploring potential therapeutic benefits.
Clinical Trial
Mar 28, 2026 1
Brain Health
SSRI Antidepressants May Block Psychedelic Effects by Reducing Brain Receptors
Swiss researchers tested whether paroxetine reduces LSD response by downregulating serotonin receptors in healthy adults.
Clinical Trial
Mar 28, 2026 1
Brain Health
Psilocybin Shows Promise for Treatment-Resistant Depression in Clinical Trial
Small study tests psychedelic compound's safety and effectiveness against severe depression that doesn't respond to standard treatments.
Clinical Trial
Mar 28, 2026 1
Brain Health
LSD Shows Promise for Treating Anxiety in Life-Threatening Illness Study
Swiss researchers tested LSD-assisted therapy for anxiety disorders in a controlled crossover trial with 46 participants.
Clinical Trial
Mar 28, 2026 1
Brain Health
Psilocybin Shows Promise for Anorexia Nervosa in Small Clinical Trial
UC San Diego researchers tested psilocybin's safety and potential benefits for eating disorder symptoms in 16 participants with anorexia nervosa.
Clinical Trial
Mar 28, 2026 1
Brain Health
Flavonoid Supplement Shows Promise for Cognitive Function in Elderly Adults
Italian researchers test plant-based compounds for brain health and quality of life in aging adults with promising early results.
Clinical Trial
Mar 28, 2026 2
Brain Health
New Alzheimer's Drug BMS-984923 Completes Safety Testing in 51 Participants
Phase 1b trial tests escalating doses of experimental Alzheimer's treatment BMS-984923 for safety and tolerability in older adults.
Clinical Trial
Mar 28, 2026 1
Brain Health
Microalgae Supplement BrainPhyt Shows Promise for Cognitive Health in Older Adults
24-week trial tested fucoxanthin-rich microalgae supplement on memory, attention, and executive function in 66 healthy seniors.
Clinical Trial
Mar 28, 2026 0
Brain Health
Virtual Reality Shows Promise for Alzheimer's and Cognitive Decline Treatment
Study tests VR therapy versus traditional cognitive training in 60 patients with mild cognitive impairment and Alzheimer's disease.
Clinical Trial
Mar 28, 2026 1
Brain Health
Actovegin Shows Promise for Cognitive Recovery After Stroke in Major Clinical Trial
Large 503-patient study tested whether Actovegin could improve thinking and memory problems that persist after stroke recovery.
Clinical Trial
Mar 28, 2026 0